Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres

about

Potential drug-drug interactions with direct oral anticoagulants in elderly hospitalized patients.

P2860

Q53076704-56F07A53-4B71-43FD-87EA-EF1B2B8596B1

P2860

Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres

Item

http://www.wikidata.org/entity/Q36161194

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres

@ast

Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres

@en

type

Item

label

Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres

@ast

Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres

@en

prefLabel

Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres

@ast

Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres

@en

P1476

Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres

@en

P2093

Aleesa A Carter

http://www.w3.org/2001/XMLSchema#string

Amita Woods

http://www.w3.org/2001/XMLSchema#string

Donna Lowe

http://www.w3.org/2001/XMLSchema#string

Kori Leblanc

http://www.w3.org/2001/XMLSchema#string

P2860

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin

Dabigatran versus warfarin in patients with atrial fibrillation

Dabigatran versus warfarin in patients with mechanical heart valves

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Dabigatran, bleeding, and the regulators

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly

Apixaban in patients with atrial fibrillation.

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.

P304

369-377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4212/CJHP.V68I5.1483

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26478582

http://www.w3.org/2001/XMLSchema#string

P932

4605460

http://www.w3.org/2001/XMLSchema#string

Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres

about

P2860

P2860

Utilization of Dabigatran for Atrial Fibrillation at 3 Tertiary Care Centres

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932